Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Biocon Limited
Press Release Mar 07 2025
Business
Mar 7 2025
4 min read

Press Release Mar 07 2025

Biocon Limited has informed the Exchange regarding a press release dated March 07, 2025, titled "Biocon Biologics Announces Positive Results from Phase 3 Study of Yesintek Biosimilar to Ustekinumab for Chronic Plaque Psoriasis".

View Attachment